Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of method for determining degradation impurities in orlistat capsules

A technology for orlistat and impurities, applied in the field of analytical chemistry, can solve the problems of inability to effectively separate and degrade impurities, and achieve the effects of high accuracy, strong specificity, and convenient operation

Active Publication Date: 2016-11-02
ZHONGSHAN WANHAN PHARM CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The impurity analysis methods of orlistat capsules published in these references cannot effectively separate the degraded impurities mentioned in the present invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of method for determining degradation impurities in orlistat capsules
  • A kind of method for determining degradation impurities in orlistat capsules
  • A kind of method for determining degradation impurities in orlistat capsules

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0043] Preparation of disruption solution:

[0044] ①. Orlistat stock solution: take an appropriate amount of orlistat capsule content powder, add acetonitrile-water mixed solution with a volume ratio of 4:1 to make a 0.5 mg / mL solution, and obtain it.

[0045] ②. Hydrochloric acid methanol destruction solution: Take an appropriate amount of orlistat capsule content powder, which is equivalent to 50 mg of orlistat, put it in a 100mL measuring bottle, add a mixed solution of methanol-water volume ratio 4:1, ultrasonically shake, Completely dissolve orlistat, add 5mL of 0.1mol / L hydrochloric acid, let stand at room temperature for 1 hour, add 5mL of 0.1mol / L sodium hydroxide solution for neutralization, and mix the solvent with a mixed solution of methanol-water volume ratio 4:1 Dilute to the mark, that is.

[0046] ③. Hydrochloric acid ethanol destruction solution: Take an appropriate amount of orlistat capsule content powder, which is equivalent to 50mg orlistat, put it in a ...

Embodiment 1

[0053] Embodiment 1: System suitability test

[0054] Instruments and experimental conditions:

[0055] High performance liquid chromatography: Shimadzu LC-16;

[0056] Chromatographic column: Cortecs C 18 (Waters, 150×4.6mm, 2.7μm);

[0057] Mobile phase A is 0.025% by volume phosphoric acid aqueous solution, and mobile phase B is acetonitrile; linear gradient elution according to Table 2.

[0058]

[0059]

[0060] The flow rate is 1.3mL / min;

[0061] Column temperature 35°C;

[0062] Detection wavelength 195nm;

[0063] The injection volume was 20 μl.

[0064] Experimental steps:

[0065] Take acetonitrile-water volume ratio is 4: 1 mixed solution and impurity mixed reference substance solution respectively, carry out high performance liquid chromatography analysis according to above-mentioned experimental conditions, record chromatogram, the result sees figure 1 , figure 2 , ORL in the figure represents orlistat. figure 2 The middle is the chromatogram co...

Embodiment 2

[0069] Embodiment 2: system suitability comparative test (USP37 method)

[0070] Instruments and experimental conditions:

[0071] High performance liquid chromatography: Shimadzu LC-16;

[0072] Chromatographic column: Nova-pak C18 (3.9mm×150mm, 4.0μm);

[0073] Mobile phase: acetonitrile-phosphoric acid-water mixed solution with a volume ratio of 88:0.05:12;

[0074] Flow rate: 1.0mL / min;

[0075] Column temperature: 35°C;

[0076] Wavelength: 195nm;

[0077] Injection volume: 20 μl.

[0078] Experimental steps:

[0079] Get impurity mixed reference substance solution, carry out high performance liquid chromatography analysis according to above-mentioned experimental conditions, record chromatogram, the result sees image 3 And Table 4, it can be found that in the method of the USP 37th edition, orlistat is not separated from the ring opener methyl ester at all, and the peaks of each impurity are relatively close, which is not conducive to separation. Therefore, th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for measuring degraded impurities in orlistat capsules and relates to the field of analytical chemistry.According to the method, a high performance liquid chromatographic method is adopted, an impurity mixed reference substance solution and a sample solution are injected in a high performance liquid chromatograph, and measurement of the degraded impurities in the orlistat capsules is completed.According to the chromatographic conditions, silica gel solid sphere particles are used as filler of a chromatographic column; a mobile phase A is an acidic water solution, a mobile phase B is an organic solvent, the sum of the percent by volume of the mobile phase A and the percent by volume of the mobile phase B is kept 100% all the time, and linear gradient elution is carried out.According to the method, the Cortecs C18 (Waters, 150 mm*4.6 mm, 2.7 micrometers) chromatographic column is adopted, and by optimizing the mobile phase gradient elution procedure, all the degraded impurities and process impurities hard to separate nearby a main peak can be separated under the same chromatographic conditions, and the degraded impurities in the orlistat capsules can be effectively detected.

Description

technical field [0001] The invention relates to the field of analytical chemistry, in particular to a method for separating and measuring degraded impurities in orlistat capsules by commonly used high-performance liquid chromatography. Background technique [0002] Orlistat was first discovered in 1987. The chemical name of Orlistat (Orlistat) is: (s)-2-formamido-4-methyl-pentanoic acid (s)-1-[[(2s, 3s )-3-hexyl-4-oxo-2oxetany]methyl-dodecyl ester, the chemical formula of which is as follows. The trade name is Xenical, which was developed by Hoffmann-La Roche in Switzerland. It was first launched in New Zealand in 1998 and in the United States in 1999. Orlistat, as a potent and long-acting gastrointestinal lipase inhibitor, is a new type of weight loss drug with non-systemic effect, good tolerance and effectiveness. Treating obesity without appetite suppressants opens up new avenues for pharmacological treatment of obesity. [0003] [0004] The degradation impurities ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06G01N2030/027
Inventor 杜志博陈嘉智邵诗雅徐小林彭韪
Owner ZHONGSHAN WANHAN PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com